Rallybio Corporation
RLYB
$0.535
$0.0715.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 36.83% | 22.52% | 5.04% | -4.76% | -9.79% |
| Total Depreciation and Amortization | -15.07% | -12.67% | -10.46% | -10.13% | -10.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.00% | -12.68% | -3.88% | -0.91% | -9.44% |
| Change in Net Operating Assets | -147.15% | -106.03% | 329.85% | 989.61% | 389.32% |
| Cash from Operations | 22.70% | 18.22% | 20.07% | 13.13% | 8.60% |
| Capital Expenditure | -- | -- | -- | -200.00% | 33.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.92% | 21.04% | 361.28% | 291.09% | 219.54% |
| Cash from Investing | -5.89% | 21.09% | 361.22% | 290.98% | 219.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,838.65% | 1,838.65% | -89.37% | -89.38% | -99.46% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -92.81% | 63.20% | 68.95% | 100.00% |
| Cash from Financing | 1,743.62% | 3,535.66% | -89.75% | -89.71% | -99.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.63% | 67.38% | 118.93% | 43.65% | 51.75% |